Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vascular Surgery

  Free Subscription


Articles published in Thromb Haemost

Retrieve available abstracts of 44 articles:
HTML format



Single Articles


    May 2020
  1. PASTORI D, Farcomeni A, Milanese A, Del Sole F, et al
    Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis.
    Thromb Haemost. 2020;120:866-875.
    PubMed     Abstract available


  2. DAI C, Chen Z, Fu J, Qian J, et al
    Cilostazol for Chinese Patients with Aspirin Intolerance after Coronary Drug-Eluting Stent Implantation.
    Thromb Haemost. 2020;120:857-865.
    PubMed     Abstract available


    March 2020
  3. RAMOTOWSKI B, Gurbel PA, Tantry U, Bracha JS, et al
    Effect of Smoking Cessation on the Pharmacokinetics and Pharmacodynamics of Clopidogrel after PCI: The Smoking Cessation Paradox Study.
    Thromb Haemost. 2020;120:449-456.
    PubMed     Abstract available


    February 2020
  4. GOROG DA, Geisler T
    Platelet Inhibition in Acute Coronary Syndrome and Percutaneous Coronary Intervention: Insights from the Past and Present.
    Thromb Haemost. 2020 Feb 19. doi: 10.1055/s-0040-1702920.
    PubMed     Abstract available


    January 2020
  5. TAVENIER AH, Hermanides RS, Fabris E, Lapostolle F, et al
    Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial.
    Thromb Haemost. 2020;120:65-74.
    PubMed     Abstract available


    December 2019
  6. BIKDELI B, McAndrew T, Crowley A, Chen S, et al
    Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology.
    Thromb Haemost. 2019 Dec 9. doi: 10.1055/s-0039-1700872.
    PubMed     Abstract available


    October 2019
  7. SQUIZZATO A, Agnelli G, Campanini M, Dentali F, et al
    Prophylaxis of Venous Thromboembolism after Hospital Discharge in Internal Medicine: Findings from the Observational FADOI-NoTEVole Study.
    Thromb Haemost. 2019 Oct 21. doi: 10.1055/s-0039-1697661.
    PubMed     Abstract available


  8. VOGEL B, Chandrasekhar J, Baber U, Mastoris I, et al
    Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry.
    Thromb Haemost. 2019;19:1704-1711.
    PubMed     Abstract available


    September 2019
  9. SCHUPKE S, Hein-Rothweiler R, Mayer K, Janisch M, et al
    Revacept, a Novel Inhibitor of Platelet Adhesion, in Patients Undergoing Elective PCI-Design and Rationale of the Randomized ISAR-PLASTER Trial.
    Thromb Haemost. 2019;119:1539-1545.
    PubMed     Abstract available


    July 2019
  10. KAIKITA K, Hosokawa K, Dahlen JR, Tsujita K, et al
    Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease.
    Thromb Haemost. 2019 Jul 22. doi: 10.1055/s-0039-1693411.
    PubMed     Abstract available


  11. ALEXOPOULOS D, Dragasis S, Kafkas N
    Loading with Oral P2Y12 Receptor Inhibitors: To Crush or Not to Crush?
    Thromb Haemost. 2019;119:1037-1047.
    PubMed     Abstract available


    June 2019
  12. GROSS L, Kupka D, Trenk D, Geisler T, et al
    Gender and Outcomes following Guided De-Escalation of Antiplatelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Gender Substudy.
    Thromb Haemost. 2019 Jun 21. doi: 10.1055/s-0039-1692441.
    PubMed     Abstract available


  13. KOMOSA A, Lesiak M, Krasinski Z, Grygier M, et al
    Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI: A Meta-Analysis.
    Thromb Haemost. 2019;119:1000-1020.
    PubMed     Abstract available


    May 2019
  14. UBAID S, Ford TJ, Berry C, Murray HM, et al
    Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial.
    Thromb Haemost. 2019 May 26. doi: 10.1055/s-0039-1688789.
    PubMed     Abstract available


  15. KANG J, Park KW, Ki YJ, Park J, et al
    Development and Validation of an Ischemic and Bleeding Risk Evaluation Tool in East Asian Patients Receiving Percutaneous Coronary Intervention.
    Thromb Haemost. 2019 May 12. doi: 10.1055/s-0039-1688792.
    PubMed     Abstract available


    April 2019
  16. KEARON C, Gu CS, Julian JA, Goldhaber SZ, et al
    Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral-Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial.
    Thromb Haemost. 2019;119:633-644.
    PubMed     Abstract available


    March 2019
  17. ZHENG YY, Wu TT, Chen Y, Hou XG, et al
    Gamma-Glutamyl Transferase-to-Platelet Ratio as a Novel Predictor of Long-Term Adverse Outcomes in Patients after Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study.
    Thromb Haemost. 2019 Mar 1. doi: 10.1055/s-0039-1681103.
    PubMed     Abstract available


    January 2019
  18. FREYNHOFER MK, Hein-Rothweiler R, Haller PM, Aradi D, et al
    Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-Study.
    Thromb Haemost. 2019 Jan 29. doi: 10.1055/s-0038-1677549.
    PubMed     Abstract available


  19. KANG J, Park KW, Palmerini T, Stone GW, et al
    Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTs.
    Thromb Haemost. 2019;119:149-162.
    PubMed     Abstract available


    December 2018
  20. TSCHARRE M, Vogel B, Tentzeris I, Freynhofer MK, et al
    Prognostic Impact of Soluble P-Selectin on Long-Term Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Dec 28. doi: 10.1055/s-0038-1676563.
    PubMed     Abstract available


    October 2018
  21. SORRENTINO S, Baber U, Claessen BE, Camaj A, et al
    Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Oct 12. doi: 10.1055/s-0038-1673687.
    PubMed     Abstract available


    August 2018
  22. KARHAUSEN JA, Qi W, Smeltz AM, Li YJ, et al
    Genome-Wide Association Study Links Receptor Tyrosine Kinase Inhibitor Sprouty 2 to Thrombocytopenia after Coronary Artery Bypass Surgery.
    Thromb Haemost. 2018 Aug 13. doi: 10.1055/s-0038-1667199.
    PubMed     Abstract available


  23. GROSS L, Trenk D, Jacobshagen C, Krieg A, et al
    Genotype-Phenotype Association and Impact on Outcomes following Guided De-Escalation of Anti-Platelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Genotyping Substudy.
    Thromb Haemost. 2018 Aug 13. doi: 10.1055/s-0038-1667337.
    PubMed     Abstract available


    June 2018
  24. COELHO-LIMA J, Mohammed A, Cormack S, Jones S, et al
    Overcoming Heparin-Associated RT-qPCR Inhibition and Normalization Issues for microRNA Quantification in Patients with Acute Myocardial Infarction.
    Thromb Haemost. 2018 Jun 11. doi: 10.1055/s-0038-1660437.
    PubMed     Abstract available


  25. SUMAYA W, Parker WAE, Fretwell R, Hall IR, et al
    Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study).
    Thromb Haemost. 2018 Jun 6. doi: 10.1055/s-0038-1657768.
    PubMed     Abstract available


  26. ALEXOPOULOS D, Xenogiannis I, Vlachakis P, Tantry U, et al
    Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Jun 4. doi: 10.1055/s-0038-1649484.
    PubMed     Abstract available


    April 2018
  27. MAHLA E, Metzler H, Bornemann-Cimenti H, Prueller F, et al
    Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
    Thromb Haemost. 2018 Apr 6. doi: 10.1055/s-0038-1641153.
    PubMed     Abstract available


  28. GARAY A, Ariza-Sole A, Formiga F, Raposeiras-Roubin S, et al
    Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry.
    Thromb Haemost. 2018 Apr 3. doi: 10.1055/s-0038-1635259.
    PubMed     Abstract available


    February 2018
  29. STOREY RF, Ardissino D, Vignali L, Cairns R, et al
    Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study.
    Thromb Haemost. 2018;118:427-429.
    PubMed    


  30. DE CARVALHO LP, Fong A, Troughton R, Yan BP, et al
    Prognostic Implications of Dual Platelet Reactivity Testing in Acute Coronary Syndrome.
    Thromb Haemost. 2018;118:415-426.
    PubMed     Abstract available


  31. BIANCARI F, Tauriainen T, Kinnunen EM, Airaksinen J, et al
    External Validation of the WILL-BLEED Risk Score.
    Thromb Haemost. 2018;118:433-434.
    PubMed    


    July 2017
  32. HARADA Y, Michel J, Lohaus R, Mayer K, et al
    Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents.
    Thromb Haemost. 2017;117.
    PubMed     Abstract available


  33. SILLER-MATULA J, Lang IM, Schoergenhofer C, Roest M, et al
    Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention.
    Thromb Haemost. 2017;117.
    PubMed     Abstract available


    June 2017
  34. CUBEDO J, Blasco A, Padro T, Ramaiola I, et al
    Molecular signature of coronary stent thrombosis: oxidative stress and innate immunity cells.
    Thromb Haemost. 2017;117.
    PubMed     Abstract available


    May 2017
  35. SEREBRUANY VL, Kim MH, Cabrera-Fuentes HA, Lee K, et al
    Mortality and cancer after 12 versus 30 months dual antiplatelet therapy. The Korean Outcomes Registry Evaluating Antithrombotics (KOREA).
    Thromb Haemost. 2017;117:934-939.
    PubMed     Abstract available


    March 2017
  36. CAMPO G, Vieceli Dalla Sega F, Pavasini R, Aquila G, et al
    Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease.
    Thromb Haemost. 2017 Mar 23. doi: 10.1160/TH16-12-0973.
    PubMed     Abstract available


    February 2017
  37. CHRISTOPOULOS C, Farag M, Sullivan K, Wellsted D, et al
    Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention.
    Thromb Haemost. 2017;117:457-470.
    PubMed     Abstract available


  38. BIANCARI F, Brascia D, Onorati F, Reichart D, et al
    Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score.
    Thromb Haemost. 2017;117:445-456.
    PubMed     Abstract available


  39. URBANSKI K, Ludew D, Filip G, Filip M, et al
    CD14+CD16++ "nonclassical" monocytes are associated with endothelial dysfunction in patients with coronary artery disease.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-08-0614.
    PubMed     Abstract available


  40. FREYNHOFER MK, Iliev L, Bruno V, Rohla M, et al
    Platelet turnover predicts outcome after coronary intervention.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-10-0785.
    PubMed     Abstract available


  41. PARK Y, Tantry US, Koh JS, Ahn JH, et al
    Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
    Thromb Haemost. 2017 Feb 2. doi: 10.1160/TH16-10-0744.
    PubMed     Abstract available


    October 2016
  42. FLIERL U, Zauner F, Sieweke JT, Berliner C, et al
    Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction.
    Thromb Haemost. 2016;117.
    PubMed     Abstract available


    September 2016
  43. SIBBING D, Aradi D, Jacobshagen C, Gross L, et al
    A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on chronic Antiplatelet Treatment for Acute Coronary Syndr
    Thromb Haemost. 2016;117.
    PubMed     Abstract available


    June 2016
  44. MEESTERS MI, Veerhoek D, de Lange F, de Vries JW, et al
    Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Thromb Haemost. 2016;116.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: